An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

被引:304
|
作者
Bruyere, Olivier [1 ,2 ]
Honvo, Germain [1 ,2 ]
Veronese, Nicola [3 ]
Arden, Nigel K. [4 ,5 ]
Branco, Jaime [6 ]
Curtis, Elizabeth M. [5 ]
Al-Daghri, Nasser M. [7 ]
Herrero-Beaumont, Gabriel [8 ]
Martel-Pelletier, Johanne [9 ]
Pelletier, Jean-Pierre [9 ]
Rannou, Francois [10 ,11 ]
Rizzoli, Rene [2 ,12 ,13 ]
Roth, Roland [14 ]
Uebelhart, Daniel [15 ]
Cooper, Cyrus [2 ,5 ,16 ]
Reginster, Jean-Yves [1 ,2 ,7 ]
机构
[1] Univ Liege, Div Publ Hlth Epidemiol & Hlth Econ, CHU Sart Tilman, B-4000 Liege, Belgium
[2] WHO Collaborating Ctr Publ Hlth Aspects Musculosk, Liege, Belgium
[3] CNR, Inst Neurosci, Aging Branch, Padua, Italy
[4] Univ Oxford, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Oxford, England
[5] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England
[6] Univ Nova Lisboa, CEDOC, NOVA Med Sch, Dept Rheumatol,CHLO,Hosp Egas Moniz, Lisbon, Portugal
[7] King Saud Univ, Chair Biomarkers Chron Dis, Dept Biochem, Coll Sci, Riyadh, Saudi Arabia
[8] Univ Autonoma, Dept Rheumatol, Bone & Joint Res Unit, Fdn Jimenez Diaz, Madrid, Spain
[9] CHUM, Res Ctr, Div Rheumatol, Osteoarthrit Res Unit, Montreal, PQ, Canada
[10] Univ Paris 05, Cochin Hosp, AP HP,Sorbonne Paris Cite, Div Phys Med & Rehabil,Dept Rheumatol, Paris, France
[11] INSERM, U1124, Paris, France
[12] Geneva Univ Hosp, Div Bone Dis, Geneva, Switzerland
[13] Fac Med, Geneva, Switzerland
[14] Max Reger Str 17-19, D-45128 Essen, Germany
[15] CVP, Hop Valais HVS, Div Musculoskeletal Internal Med & Oncol Rehabil, Dept Orthopaed & Traumatol,CHVR, CH-3963 Crans Montana, Switzerland
[16] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Oxford, England
关键词
Algorithm; Recommendations; GRADE; Treatment; Knee osteoarthritis; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTRAARTICULAR HYALURONIC-ACID; LIFE SETTING TRIALS; QUALITY-OF-LIFE; CRYSTALLINE GLUCOSAMINE SULFATE; INDIVIDUAL PATIENT DATA; G-F; 20; DOUBLE-BLIND; CHONDROITIN SULFATE; HIP OSTEOARTHRITIS;
D O I
10.1016/j.semarthrit.2019.04.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) sought to revisit the 2014 algorithm recommendations for knee osteoarthritis (OA), in light of recent efficacy and safety evidence, in order to develop an updated stepwise algorithm that provides practical guidance for the prescribing physician that is applicable in Europe and internationally. Methods: Using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) process, a summary of evidence document for each intervention in OA was provided to all members of an ESCEO working group, who were required to evaluate and vote on the strength of recommendation for each intervention. Based on the evidence collected, and on the strength of recommendations afforded by consensus of the working group, the final algorithm was constructed. Results: An algorithm for management of knee OA comprising a stepwise approach and incorporating consensus on 15 treatment recommendations was prepared by the ESCEO working group. Both "strong" and "weak" recommendations were afforded to different interventions. The algorithm highlights the continued importance of non-pharmacological interventions throughout the management of OA. Benefits and limitations of different pharmacological treatments are explored in this article, with particular emphasis on safety issues highlighted by recent literature analyses. Conclusions: The updated ESCEO stepwise algorithm, developed by consensus from clinical experts in OA and informed by available evidence for the benefits and harms of various treatments, provides practical, current guidance that will enable clinicians to deliver patient-centric care in OA practice. (C) 2019 The Authors. Published by Elsevier Inc.
引用
收藏
页码:337 / 350
页数:14
相关论文
共 50 条
  • [1] MANAGEMENT OF KNEE OSTEOARTHRITIS IN 2019: AN UPDATED ALGORITHM FROM THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES (ESCEO)
    Reginster, J. -Y.
    Bruyere, Olivier
    Honvo, Germain
    Veronese, Nicola
    Arden, Nigel K.
    Branco, Jaime
    Curtis, Elizabeth
    Al-Daghri, Nasser M.
    Herrero-Beaumont, Gabriel
    Hochberg, Marc C.
    Martel-Pelletier, Johanne
    Pelletier, Jean-Pierre
    Rannou, Francois
    Rizzoli, Rene
    Roth, Roland
    Uebelhart, Daniel
    Cooper, Cyrus
    Reginster, Jean-Yves
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S158 - S159
  • [2] An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
    Bruyere, Olivier
    Cooper, Cyrus
    Pelletier, Jean-Pierre
    Branco, Jaime
    Brandi, Maria Luisa
    Guillemin, Francis
    Hochberg, Marc C.
    Kanis, John A.
    Kvien, Tore K.
    Martel-Pelletier, Johanne
    Rizzoli, Rene
    Silverman, Stuart
    Reginster, Jean-Yves
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2014, 44 (03) : 253 - 263
  • [3] Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)
    Biver, Emmanuel
    Berenbaum, Francis
    Valdes, Ana M.
    de Carvalho, Islene Araujo
    Bindels, Laure B.
    Brand, Maria Luisa
    Calder, Philip C.
    Castronovo, Vincenzo
    Cavalier, Etienne
    Cherubini, Antonio
    Cooper, Cyrus
    Dennison, Elaine
    Franceschi, Claudio
    Fuggle, Nicholas
    Laslop, Andrea
    Miossec, Pierre
    Thomas, Thierry
    Tuzun, Sansin
    Veronese, Nicola
    Vlaskovska, Mila
    Reginster, Jean-Yves
    Rizzoli, Rene
    [J]. AGEING RESEARCH REVIEWS, 2019, 55
  • [4] AN ALGORITHM GUIDELINE FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS IN EUROPE: A REPORT FROM A TASKFORCE OF THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS AND OSTEOARTHRITIS (ESCEO)
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S138 - S138
  • [5] Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Reginster, Jean-Yves L.
    Arden, Nigel K.
    Haugen, Ida K.
    Rannou, Francois
    Cavalier, Etienne
    Bruyere, Olivier
    Branco, Jaime
    Chapurlat, Roland
    Basset, Sabine Collaud
    Al-Daghri, Nasser M.
    Dennison, Elaine M.
    Herrero-Beaumont, Gabriel
    Laslop, Andrea
    Leeb, Burkhard F.
    Maggi, Stefania
    Mkinsi, Ouafa
    Povzun, Anton S.
    Prieto-Alhambra, Daniel
    Thomas, Thierry
    Uebelhart, Daniel
    Veronese, Nicola
    Cooper, Cyrus
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (01) : 1 - 8
  • [6] Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Olivier Bruyère
    Cyrus Cooper
    Nasser M. Al-Daghri
    Elaine M. Dennison
    René Rizzoli
    Jean-Yves Reginster
    [J]. Aging Clinical and Experimental Research, 2018, 30 : 111 - 117
  • [7] RECOMMENDATIONS FOR THE REPORTING OF HARMS IN MANUSCRIPTS ON STUDIES ASSESSING OSTEOARTHRITIS DRUGS: A CONSENSUS STATEMENT FROM THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES (ESCEO)
    Honvo, G.
    Bannuru, R. R.
    Bruyere, O.
    Rannou, F.
    Herrero-Beaumont, G.
    Uebelhart, D.
    Cooper, C.
    Arden, N.
    Conaghan, P. G.
    Reginster, J. -Y.
    Thomas, T.
    McAlindon, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S569 - S570
  • [8] Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Germain Honvo
    Raveendhara R. Bannuru
    Olivier Bruyère
    Francois Rannou
    Gabriel Herrero-Beaumont
    Daniel Uebelhart
    Cyrus Cooper
    Nigel Arden
    Philip G. Conaghan
    Jean-Yves Reginster
    Thierry Thomas
    Tim McAlindon
    [J]. Drugs & Aging, 2019, 36 : 145 - 159
  • [9] Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Bruyere, Olivier
    Cooper, Cyrus
    Al-Daghri, Nasser M.
    Dennison, Elaine M.
    Rizzoli, Rene
    Reginster, Jean-Yves
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 30 (02) : 111 - 117
  • [10] Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Honvo, Germain
    Bannuru, Raveendhara R.
    Bruyere, Olivier
    Rannou, Francois
    Herrero-Beaumont, Gabriel
    Uebelhart, Daniel
    Cooper, Cyrus
    Arden, Nigel
    Conaghan, Philip G.
    Reginster, Jean-Yves
    Thomas, Thierry
    McAlindon, Tim
    [J]. DRUGS & AGING, 2019, 36 (Suppl 1) : 145 - 159